Forecasting & Modelling
Model Systems & Tools
Comments & Editorials
CDC Weekly Reports
Genes or Proteins
Select virus of interest
Registered clinical trials for treating the virus
Published and Preprint Papers
C1 Esterase Inhibitor (Human)
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Characteristics and outcomes of COVID-19 in Chinese immune thrombocytopenia patients: A prospective cohort study.
Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1 study.
Early mobilisation in critically ill COVID-19 patients: a subanalysis of the ESICM-initiated UNITE-COVID observational study.
Comparison of the 12-month impact of COVID-19 and SARS on physiological capacity and health-related quality of life.
Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot Trial.
Pharmacokinetics, Safety, and Tolerability of Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Delivered Intravenously or Intramuscularly in Japanese and Caucasian Healthy Volunteers.
AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cancer.
Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trial.
Effectiveness of an amygdala and insula retraining program combined with mindfulness training to improve the quality of life in patients with long COVID: a randomized controlled trial protocol.